Author

Wouter B. Nagengast 1

1 University Medical Center Groningen,Groningen,Netherlands

ENDOCYTOSCOPIC IDENTIFICATION OF DYSPLASIA IN THE BARRETT’S OESOPHAGUS USING ARTIFICIAL INTELLIGENCE AS A SECOND ASSESSOR: A PROSPECTIVE ASSESSMENT OF THE INTERACTION BETWEEN GASTROENTEROLOGISTS AND A CONVOLUTIONAL NEURAL NETWORK ALGORITHM

Xiaojuan Zhao, Jouke van der Laan, Joost A. van der Putten, Iris Schmidt, Arend Karrenbeld, Frans Peters, Ruben Yannick Gabriëls, Wouter B. Nagengast, Fons van der Sommen, Jessie Westerhof

ENDOSCOPIC FOLLOW-UP OF RADICALLY RESECTED HIGH-RISK MUCOSAL ADENOCARCINOMA AND LOW- AND HIGH-RISK SUBMUCOSAL ADENOCARCINOMA ARISING IN BARRETT'S ESOPHAGUS, RESULTS OF 120 PATIENTS FROM THE DUTCH BARRETT EXPERT CENTER COHORT

Esther Nieuwenhuis, Sanne van Munster, Bas L.A.M. Weusten, Alaa Alkhalaf, Boudewijn Edwin Schenk, Erik Jan Schoon, Wouter L. Curvers, Arjun D. Koch, Steffi E.M. van de Ven, Eva Verheij, Aydan Kumcu, Wouter B. Nagengast, Martin Houben, Jacques J. Bergman, Roos E. Pouw

ENDOSCOPIC SUBMUCOSAL DISSECTION FOR BARRETT'S RELATED NEOPLASIA IN THE NETHERLANDS: RESULTS OF A NATIONWIDE COHORT OF 130 CASES

Eva Verheij, Sanne van Munster, George Johan Arnold Offerhaus, Lodewijk Brosens, Sybren L. Meijer, Erik Jan Schoon, Bas L.A.M. Weusten, Boudewijn Edwin Schenk, Wouter L. Curvers, Arjun D. Koch, Jacques J. Bergman, Laurèlle Van Tilburg, Martin Houben, Steffi E.M. van de Ven, Thjon J. Tang, Roos E. Pouw, Wouter B. Nagengast;;

FEASIBILITY, SAFETY, TOLERABILITY AND DOSE-RELATED EFFICACY OF A NOVEL SWIPE CRYOBALLOON ABLATION (90⁰-SCBA) DEVICE IN DYSPLASTIC BARRETT'S ESOPHAGUS

Anouk Overwater, Sanne N. van Munster, G.M. Raicu, C.A. Seldenrijk, Wouter B. Nagengast, Erik Jan Schoon, Jacques J.G.H.M. Bergman, Bas L.A.M. Weusten

FLUORESCENCE MOLECULAR ENDOSCOPY USING CETUXIMAB-800CW TO EVALUATE THE RESPONSE TO NEOADJUVANT CHEMORADIOTHERAPY IN LOCALLY ADVANCED RECTAL CANCER: PRELIMINARY RESULTS

Wouter B. Nagengast, Anne M. van der Waaij, Gursah Kats-Ugurlu, T. van Etten, Wouter T. R. Hooghiemstra

IDENTIFICATION AND VALIDATION OF NOVEL TARGETS FLUORESCENCE MOLECULAR ENDOSCOPY FOR NEOPLASIA DETECTION IN BARRETT’S ESOPHAGUS

Ruben Y. Gabriëls, Xiaojuan Zhao, Wouter Hooghiemstra, Pia Volkmer, Marjory Koller, Lydia Visser, Gert Jan Meersma, Gursah Kats-Ugurlu, Arend Karrenbeld, Wouter B. Nagengast, Rudolf Fehrmann

Long-term outcomes after endoscopic treatment for Barrett's neoplasia in 641 patients in a centralized care setting in the Netherlands: recurrent neoplasia is rare and neosquamous biopsies do not contribute to its detection

Sanne van Munster, Esther Nieuwenhuis, Bas L.A.M. Weusten, Lorenza Alvarez Herrero, Auke Bogte, Alaa Alkhalaf, Boudewijn Edwin Schenk, Erik Jan Schoon, Wouter L. Curvers, Arjun D. Koch, Steffi E.M. van de Ven, Wouter B. Nagengast, Frans Peters, Martin Houben, Roos E. Pouw, Jacques J. Bergman

POOR HEALING AND POOR SQUAMOUS REGENERATION AFTER RADIOFREQUENCY ABLATION THERAPY FOR EARLY BARRETT'S NEOPLASIA: INCIDENCE, RISK FACTORS, AND OUTCOMES

Sanne van Munster, Charlotte N. Frederiks, Lorenza Alvarez Herrero, Auke Bogte, Alaa Alkhalaf, Boudewijn Edwin Schenk, Erik Jan Schoon, Wouter L. Curvers, Arjun D. Koch, Steffi E.M. van de Ven, Pieter Jan De Jonge, Thjon J. Tang, Wouter B. Nagengast, F.T.M. Peters, Jessie Westerhof, Martin Houben, Jacques J. Bergman, Roos

The optimal imaging window for molecular fluorescence endoscopy using a c-Met targeted fluorescent peptide for the detection of dysplastic colorectal polyps

S.J. de Jongh, Josine Vrouwe, Floris J. Voskuil, Iris Schmidt, Jessie Westerhof, Jan Jacob Koornstra, Arend Karrenbeld, Ingrid M.C. Kamerling, Dominic J. Robinson, Jacobus Burggraaf, James C.H. Hardwick, Wouter B. Nagengast

Item 1 - 9 / 10
1